Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival

Journal of International Medical Research

Volumn 41, Issue 3, 2013, Pages 596-602

  Li, Yuyang ^a   Hong, Fanzhen ^a   Yu, Zhigang ^a  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

breast cancer; metastasis; MicroRNA 206 (miR 206); prognosis; tumour stage

Indexed keywords

MICRORNA; MICRORNA 206; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

BREAST CANCER; METASTASIS; MICRORNA-206 (MIR-206); PROGNOSIS; TUMOUR STAGE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84887330709     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513485856     Document Type: Article

References (31)

1. Jemal A,Siegel R,Ward E,et al.Cancer statistics, 2008.CA Cancer J Clin. 2008;58:71-96.
2. Gonzalez-Angulo AM,Morales-Vasquez F,Hortobagyi GN.Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22.
3. Ambros V.MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing.Cell. 2003;113:673-676.
4. Calin GA,Dumitru CD,Shimizu M,et al.Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.Proc Natl Acad Sci USA. 2002;99:15524-15529.
5. Calin GA,Sevignani C,Dumitru CD,et al.Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.Proc Natl Acad Sci USA. 2004;101:2999-3004.
6. Fabian MR,Sonenberg N.The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC.Nat Struct Mol Biol. 2012;19:586-593.
7. Ahmad A,Aboukameel A,Kong D,et al.Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.Cancer Res. 2011;71:3400-3409.
8. Adams BD,Guttilla IK,White BA.Involvement of microRNAs in breast cancer.Semin Reprod Med. 2008;26:522-536.
9. Wang X,Ling C,Bai Y,et al.MicroRNA-206 is associated with invasion and metastasis of lung cancer.Anat Rec (Hoboken). 2011;294:88-92.
10. Missiaglia E,Shepherd CJ,Patel S,et al.MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas.Br J Cancer. 2010;102:1769-1777.
11. Chen X,Yan Q,Li S,et al.Expression of the tumour suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma.Cancer Lett. 2012;314:41-53.
12. Iorio MV,Ferracin M,Liu CG,et al.MicroRNA gene expression deregulation in human breast cancer.Cancer Res. 2005;65:7065-7070.
13. Oken MM,Creech RH,Tormey DC,et al.Toxicity and response criteria of the Eastern Cooperative Oncology Group.Am J Clin Oncol. 1982;5:649-655.
14. Scarff RW,Torloni HIn: International histological classification of tumours, No. 2. Geneva: World Health Organization, Geneva; 1968:13-20.
15. Singletary SE,Allred C,Ashley P,et al.Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual.Surg Clin North Am. 2003;83:803-819.
16. Schmittgen TD,Livak KJ.Analyzing real-time PCR data by the comparative C(T) method.Nat Protoc. 2008;3:1101-1108.
17. Iorio MV,Ferracin M,Liu CG,et al.MicroRNA gene expression deregulation in human breast cancer.Cancer Res. 2005;65:7065-7070.
18. Barcenas CH,Wells J,Chong D,et al.Race as an independent risk factor for breast cancer survival: breast cancer outcomes from the medical college of Georgia tumour registry.Clin Breast Cancer. 2010;10:59-63.
19. Jovanovic M,Hengartner MO.miRNAs and apoptosis: RNAs to die for.Oncogene. 2006;25:6176-6187.
20. Casalini P,Iorio MV.MicroRNAs and future therapeutic applications in cancer.J BUON. 2009;14:S17-S22.
21. Kong YW,Ferland-McCollough D,Jackson TJ,et al.microRNAs in cancer management.Lancet Oncol. 2012;13:e249-e258.
22. Kasinski AL,Slack FJ.Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.Nat Rev Cancer. 2011;11:849-864.
23. Leivonen SK,Mäkelä R,Ostling P,et al.Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.Oncogene. 2009;28:3926-3936.
24. Taulli R,Bersani F,Foglizzo V,et al.The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation.J Clin Invest. 2009;119:2366-2378.
25. Kondo N,Toyama T,Sugiura H,et al.miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.Cancer Res. 2008;68:5004-5008.
26. Zhang T,Liu M,Wang C,et al.Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.Anticancer Res. 2011;31:3859-3863.
27. Vickers MM,Bar J,Gorn-Hondermann I,et al.Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease.Clin Exp Metastasis. 2012;29:123-132.
28. Miyachi M,Tsuchiya K,Yoshida H,et al.Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma.Biochem Biophys Res Commun. 2010;400:89-93.
29. Song G,Zhang Y,Wang L.MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumour cell migration and focus formation.J Biol Chem. 2009;284:31921-31927.
30. Bartel DP,Chen CZ.Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs.Nat Rev Genet. 2004;5:396-400.
31. Krek A,Grün D,Poy MN,et al.Combinatorial microRNA target predictions.Nat Genet. 2005;37:495-500.